Pembrolizumab Monoclonal Antibody from Japan
Pembrolizumab (Keytruda) is a humanized IgG4 monoclonal antibody blocking PD-1 for immunotherapy in melanoma and lung cancer. HTS 3002.13.0010 for unmixed biotech monoclonal antibodies regulating immunology. Supplied in bulk, non-retail.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Align with FDA's RPDR for real-time import status tracking
• Include ADCC assay data for potency verification